Clinical trial
Intravenous Injection Versus Transhepatic Intracholecystic Injection of Indocyanine Green (ICG) to Outline Biliary Tree During Laparoscopic Cholecystectomy
NCT06629415 is registered in ClinicalTrials.gov with Theodor Bilharz Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravenous Injection Versus Transhepatic Intracholecystic Injection of Indocyanine Green (ICG) to Outline Biliary Tree During Laparoscopic Cholecystectomy
- Lead sponsor
- Theodor Bilharz Research Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 5, 2022
- Completion date
- May 10, 2024
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic calculous cholecystitis, laparoscopic cholecystectomy